Critical Care Medicine
Oxygen Tissue Saturation Is Lower in Nonsurvivors than in Survivors after Early Resuscitation of Septic Shock
Leone, Marc M.D., Ph.D.*; Blidi, Sami M.D.†; Antonini, François M.D.*; Meyssignac, Bertrand M.D.†; Bordon, Sébastien M.D.†; Garcin, Frédéric M.D.‡; Charvet, Aude M.D.‡; Blasco, Valéry M.D.*; Albanèse, Jacques M.D., Ph.D.§; Martin, Claude M.D.∥
Background: Growing evidence suggests that the microvascular dysfunction is the key element of the pathogenesis of septic shock. This study's purpose was to explore whether the outcome of septic shock patients after early resuscitation using early goal-directed therapy is related to their muscle tissue oxygenation.
Methods: Tissue oxygen saturation (Sto2) was monitored in septic shock patients using a tissue spectrometer (InSpectra Model 325; Hutchinson Technology, Hutchinson, MN). For the purpose of this retrospective study, the Sto2 values were collected at the first measurement done after the macrohemodynamic variables (mean arterial pressure, urine output, central venous saturation in oxygen) were optimized.
Results: After the hemodynamic variables were corrected, no difference was observed between the nonsurvivors and survivors, with the exception of pulse oximetry saturation (94% [92–97%] vs. 97% [94–99%], P = 0.04). The Sto2 values were significantly lower in the nonsurvivors than in the survivors (73% [68–82%] vs. 84% [81–90%], P = 0.02). No correlations were found between the Sto2 and Spo2 (P = 0.7).
Conclusions: In septic shock patients, tissue oxygen saturation below 78% is associated with increased mortality at day 28. Further investigations are required to determine whether the correction of an impaired level of tissue oxygen saturation may improve the outcome of these patients.
IN septic shock, guidelines recommend an early correction of mean arterial pressure, urine output, and central or mixed venous saturation in oxygen.1
However, growing evidence suggests that the microvascular dysfunction is the key element in sepsis.2
This dysfunction may be associated with impaired outcome.3
At first glance, the correction of macrohemodynamics does not preclude whether or not the microvascular dysfunction continues.
Near-infrared spectroscopy is a noninvasive monitoring, providing real-time feedback.4
Near-infrared spectroscopy monitors only vessels with a diameter of less than 1 mm because the high concentration of blood in arteries and veins makes photon emergence unlikely. Near-infrared light (600–800 nm) easily crosses biologic tissues and is absorbed by hemoglobin, myoglogin, and oxidized cytochrome, as described elsewhere.5
This tool can quantify microvascular dysfunction in patients with septic shock.6
One can hypothesize that near-infrared spectroscopy can detect a potential microvascular dysfunction in the patients adequately resuscitated from a macrohemodynamic standpoint. The purpose of this study was to explore whether the outcome of the septic shock patients after early resuscitation using early goal-directed therapy was related to their muscle tissue oxygenation.
Materials and Methods
This study was retrospectively conducted in a 16-bed intensive care unit of an 800-bed university hospital (Hôpital Nord, Marseille, France). Informed consent and approval by the Ethics Committee were waived due to the observational nature of the study.
Septic shock was defined according to the criteria of the International Sepsis Definitions Conference.7
All patients received fluid expansion (crystalloids or 6% hydroxyethyl starch) and then required norepinephrine to raise mean arterial pressure to 65 mmHg or more.1
All patients received broad-spectrum antibiotic coverage, usually a β-lactam and a quinolone. Vancomcyin was added when oxacillin-resistant staphylococci were suspected. All patients needed mechanical ventilation and sedatives because of acute respiratory failure. According to previously conducted studies, 50 patients with septic shock were expected within a 1-year period. Thus, all the patients with septic shock were included during a 1-year period (2007).
Heart rate, mean arterial pressure, oxygen plethysmography, and end-tidal carbon dioxide were continuously monitored (Moniteur Patient Intellivue MP 70; Philips, Andover, MA). All patients had an arterial catheter and a central venous catheter placed through the subclavian vein. The arterial and venous catheters were connected to a Picco-Plus monitor (Pulsion Medical Systems, Munich, Germany) in the patients in whom vascular accesses made it possible to insert this monitoring system. This monitoring is based on the transpulmonary thermodilution technique and arterial pulse contour analysis.8
An indwelling urinary catheter was inserted in each patient. Urine was collected via
a urinometer (Curity 0123; Kendall, Hands, United Kingdom). The following variables were prospectively collected: heart rate, mean arterial pressure, central venous saturation in oxygen (Scvo2
), pulse pressure variations if its measure seemed relevant to the attending physician (sinusal rhythm, no right heart failure, controlled ventilation), cardiac index if available, lactate plasma level, pulse oximetry saturation (Spo2
), hemoglobin, creatinine plasma concentration and urine output. Demographic data, severity score (simplified acute physiology score II),9
and sedation score (Ramsay score)10
were retrospectively collected. Our local protocol was aimed at correcting macrohemodynamic variables (mean arterial pressure, urine output, Scvo2
). Initial resuscitation consisted of intravenous fluid targeted to achieve pulse pressure variations below 13% in the patients with equipment.11
If the patients were not equipped, echocardiography (respiratory variation in inferior vena cava diameter) analysis and passive leg raising (pulse pressure variations below 10%) were used.12,13
The fluid resuscitation was stopped at the discretion of the attending if pulmonary edema was suspected. Norepinephrine dosage was adjusted to achieve a mean arterial pressure of at least 65 mmHg or to maintain urine output above 0.5 ml · kg–1
After the mean arterial pressure and preload were optimized, if the Scvo2
was less than 70%, dobutamine was added at an initial dose of 5 μg · kg–1
. Ventilatory parameters were adjusted to raise arterial oxygen saturation more than 90%, and blood hemoglobin level was raised to more than 8 g/dl in patients with acute anemia.
Tissue Oxygenation Measurements
From 2006, tissue oxygen saturation (Sto2
) of the patients with septic shock was monitored in routine by using a tissue spectrometer (InSpectra Model 325; Hutchinson Technology, Hutchinson, MN). The device uses reflectance mode probes to measure scattering light reflected at some distance from where the light is transmitted into the tissue. The maximum depth of the tissue sample was estimated to equal half the distance between the probe's sending and receiving fibers.15
We used probe spacing of 15 mm. A light-scattering calibrator was used to normalize the tissue spectrometer during startup of the system and before each measurement. Sample measurement signals were updated every 3.5 s.
For the purpose of the study, the Sto2 values were collected at the first measurement done after the macrohemodynamic variables seemed optimal according to the decision of the attending physician. Briefly, preload was optimized (pulse pressure variations below 13% or lack of response to passive leg raising or no respiratory variations of the inferior vena cava diameter or pulmonary edema), mean arterial pressure was above 65 mmHg, urine output was above 0.5 ml/kg of body weight (except in the patients with acute renal failure), and the Scvo2 was at 70% or more. At the measurement time, at least three of these aims had to be achieved in all patients. The near-infrared spectroscopy probe was placed on the clean skin of the thenar eminence. After a 3-min period to stabilize the near-infrared spectroscopy signal, the value of Sto2 was recorded. A brief clinical assessment was performed by assessing the capillary refill time (less than 2 s) and the temperature at the level of the big toe (cold or hot). This assessment was done by two investigators (Drs. Blidi and Meyssignac).
To ensure that the data are not unique to the thenar eminence and not representative of the rest of the body, we included a second cohort of patients with septic shock after the macrohemodynamic variables were optimized as previously described. In this cohort, the values of Sto2 were successively recorded at three sites: thenar, deltoid, and masseter.
Statistical calculations were performed using the software package SPSS 15.0 (SPSS Inc., Chicago, IL) For continuous and ordinal variables, data were expressed as median with interquartile range (25–75% quartiles). For dichotomous variables, percentages were calculated. Comparisons between two groups (survivors and nonsurvivors) were performed with the Mann–Whitney U test. Comparisons of percentages were performed with the Fisher exact test. Comparisons of two continuous variables were performed using a linear regression. Comparisons between the three groups of the second cohort were made using the Kruskal-Wallis test. Discrimination of values was assessed with the receiver operating characteristic analysis. Sensitivity and specificity were also computed. All comparisons were two-tailed, and P < 0.05 was required to exclude the null hypothesis.
Forty-two consecutive patients with septic shock were included in the study. Their characteristics are shown in table 1
. Mortality at day 28 occurred in 13 (31%) patients (table 1
). Three patients (23%) did not survive on day 3. The objectives of mean arterial pressure, urine output, and Scvo2
were achieved in 42 (100%), 36 (86%), and 35 (84%) patients, respectively. After the hemodynamic variables were optimized, no difference was observed between the survivors and nonsurvivors, with the exception of Spo2
, which was significantly lower in the nonsurvivors than in the survivors (94% [92–97%] vs.
97% [94–99%], P
= 0.04) (table 2
). Clinically, 22 (77%) of the survivors had a capillary refill time of less than 2 s, as compared with 13 (77%) of the nonsurvivors (P
= 1.00). The big toe temperature was hot in 18 (63%) survivors and 8 (61%) nonsurvivors (P
= 0.7). Interestingly, the Sto2
values were significantly lower in the nonsurvivors than in the survivors (73% [68–82%] vs.
84% [81–90%], P
= 0.02) (fig. 1
A receiver operating characteristic analysis confirmed that Sto2
was significantly associated mortality with an area under the curve at 71% (52–91%, P
= 0.03) (fig. 2
). This association was not found for Scvo2
, lactate plasma level, and norepinephrine dosage (fig. 2
). A threshold of Sto2
at 78% was associated with a sensitivity of 61% and a specificity of 87%. Nine (64%) patients whose Sto2
was below 78% did not survive, as compared with five (36%) patients with the Sto2
equal to or above 78% (P
Next, we searched for correlations between the Sto2
and other variables. The Sto2
was not correlated with the Spo2
B), or urine output (fig. 3
C). There was also no correlation with mean arterial pressure (P
= 0.7, R2
= 0.02), cardiac index (P
= 0.2, R2
= 0.03), hemoglobin (P
= 0.8, R2
= 0.02), Ramsay score (P
= 0.2, R2
= 0.02) and norepinephrine dosage (P
= 0.9, R2
= 0.02). In contrast, the lactate plasma level was correlated with Sto2
Finally, in a new cohort of nine patients, we tested three distinct sites: thenar, masseter, and deltoid. Briefly, the two cohorts were similar in age (54 [40–59] vs. 59 [51–69] yrs, P = 0.3), sex ratio (33 vs. 33%, P = 1), SAPS II (50 [43–53] vs. 47 [38–58], P = 0.8), mean arterial pressure (84 [71–85] vs. 80 [72–85] mmHg, P = 0.9), urine output (50 [45–120] vs. 60 [40–100] ml · kg–1 · h–1, P = 0.5), and Scvo2 (76 [73–82] vs. 78 [71–84] %, P = 0.9). Sto2 measured at the thenar eminence did not differ between the two cohorts (84 [80–89] vs. 78 [71–84] %, P = 0.4). No difference was found among the three sites of measurement (84 [80–89] vs. 89 [81–90] vs. 85 [78–90] %, P = 0.7).
Our results show that, in a real-life study, after the macrohemodynamic variables were optimized, the Sto2 of the nonsurvivors at day 28 was significantly lower than that of the survivors. A value of Sto2 below 78% was associated with an increased risk of mortality. With the exception of plasma lactate levels, this variable was not correlated with the other markers of arterial oxygenation. As a result, this monitoring can provide an easy and direct tool to assess the risk of mortality in septic shock patients. In contrast, the impact of treatment aimed at correcting the Sto2 should be investigated in future studies.
At the bedside, it is challenging to identify the microcirculation dysfunction. In the current study, the clinical assessment using capillary refill time and big toe temperature did not provide relevant information. Several methods have been reported to assess the microvascular blood flow.16
Intravital microscopy is considered the standard for in vivo
investigation of the microcirculation. This technique can be used for investigation of thin tissues that allow transillumination, whereas fluorescent dyes must be used to allow epiillumination of thicker organ surfaces. Unfortunately, the use of dyes in humans is hindered by safety concerns. Thus, intravital microscopy studies have been limited to observation of nail fold capillaries that can be observed without using dyes. Other techniques like laser-Doppler flowmetry, orthogonal polarization spectral imaging, and the sidestream dark field imaging are of major interest but remain difficult to use in real-life conditions. Our approach was to give priority to being noninvasive, being user-friendly, providing real-time feedback, and influencing mortality. The use of near-infrared spectroscopy responded to these specifications.
In a previously published study, the same monitoring detected altered recovery after an ischemic challenge in patients with septic shock.5
The presence and persistence of such alterations in the first 24 h of sepsis were associated with impaired outcome. However, this technique consists on stopping arterial blood flow by inflating the cuff to 50 mmHg above the systolic arterial pressure. After 3 min of ischemia, cuff pressure is released, and Sto2
is recorded continuously for another 3-min period. The slope of the increase in Sto2
and the difference between the maximum Sto2
value during hyperemic phase and the baseline Sto2
are calculated. Although this technique provides interesting results, our approach offers a direct and continuous measurement available at the bedside. In addition, different sites of measurements seem available without affecting the significance of results.
The association between Sto2
and outcome has already been reported in trauma patients.17,18
In the emergency room, the information about Sto2
allows for discriminating the patients who would later go on to develop multiorgan dysfunction syndrome or die.17
In the current study, the Sto2
also discriminates the patients with poor outcome. The univariate analysis shows that the Spo2
is lower in the nonsurvivors than in the survivors. One may hypothesize that Sto2
is mainly dependent on Spo2
. However, no correlation was found between the Sto2
. This result is in agreement with an experimental study, concluding that muscle tissue does not show changes reflecting a greater deoxygenation during acute hypoxia.19
As a result, the monitoring of Sto2
provides information about tissue oxygenation, which is independent of arterial oxygenation.
The patients with Sto2
below 78% are at increased risk of mortality. No specific intervention was conducted regarding the correction of the low values of Sto2
. The goal of our protocol was aimed at correcting low Scvo2
. The Scvo2
was above 65% in all patients but one. Six patients had values ranged from 65% to 70%. The prognosis value of this variable has been shown in the early phase of the management of patients with severe sepsis.20,21
However, its relevance remains unknown after the patients are resuscitated. According to our study, with the exception of a type 2 error, the accuracy of Sto2
to predict mortality seems superior to that of Scvo2
. In addition, our findings confirm previous studies in which the correlation between the two variables is poor or lacking.22,23
However, we cannot conclude that the correction of Sto2
above 78% would be an efficient measure to improve outcome.
Several limitations should be acknowledged. The study is of a small number of subjects at a single timepoint. The interpretation of nonsignificant results can result from a lack of power. Thus, it is difficult to discern between nonmeaningful differences existing versus
lack of power to detect them. Use of eminence thenar may raise some issues. Indeed, the measurements may reflect changes in skin circulation at a depth of 7.5 mm. One can argue that this circulation is not representative of other circulations in our patients. To reduce this uncertainty, we tested three distinct sites in nine other patients: thenar, masseter, and deltoid. No difference was observed among the three sites, indicating that our results may be replicated by using other sites of measurement. However, in healthy volunteers, Sto2
determined from deep muscle, not thenar eminence, was an indicator of central hypovolemia.24
Thus, new technologies can improve the relevance of measurements. The use of 25-mm probes, instead of 15 mm, can also affect the results because the presumed depth of penetration is half of the path length.18
This specific point requires future investigations. Finally, we did not explore Sto2
change over time because the study was aimed at assessing the microcirculation at a specific time. One should admit that this did not improve outcome even though resuscitation increased Sto2
. However, the dynamic changes of Sto2
over time are probably an interesting field of experimentation.
In conclusion, after the macrohemodynamic variables were optimized, the monitoring of Sto2 can discriminate the patients at high risk of mortality. We determined that a Sto2 below 78% is associated with an increased mortality. The impact of possible therapeutic aimed at increasing the Sto2 was not explored in the current study. There is a need of further investigations to test such hypothesis.
1.Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296–327
2.Spronk PE, Zandstra DF, Ince C: Bench-to-bedside review: Sepsis is a disease of the microcirculation. Crit Care 2004; 8:462–8
3.Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32:1825–31
4.Creteur J: Muscle StO2 in critically ill patients. Curr Opin Crit Care 2008; 14:361–6
5.Creteur J, Carollo T, Soldati G, Buchele G, De Backer D, Vincent JL: The prognostic value of muscle StO2 in septic patients. Intensive Care Med 2007; 33:1549–56
6.De Blasi RA, Palmisani S, Alampi D, Mercieri M, Romano R, Collini S, Pinto G: Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock. Intensive Care Med 2005; 31:1661–8
7.Calandra T, Cohen J: International Sepsis Forum Definition of Infection in the ICU Consensus Conference: The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 2005; 33:1538–48
8.Spöhr F, Hettrich P, Bauer H, Haas U, Martin E, Böttiger BW: Comparison of two methods for enhanced continuous circulatory monitoring in patients with septic shock. Intensive Care Med 2007; 33:1805–10
9.Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957–63
10.Carrasco G: Instruments for monitoring intensive care unit sedation. Crit Care 2000; 4:217–25
11.Michard F: Changes in arterial pressure during mechanical ventilation. Anesthesiology 2005; 103:419–28
12.Feissel M, Michard F, Faller JP, Teboul JL: The respiratory variation in inferior vena cava diameter as a guide to fluid therapy. Intensive Care Med 2004; 30:1834–7
13.Boulain T, Achard JM, Teboul JL, Richard C, Perrotin D, Ginies G: Changes in BP induced by passive leg raising predict response to fluid loading in critically ill patients. Chest 2002; 121:1245–52
14.Bourgoin A, Leone M, Delmas A, Garnier F, Albanèse J, Martin C: Increasing mean arterial pressure in patients with septic shock: Effects on oxygen variables and renal function. Crit Care Med 2005; 33:780–6
15.Cui W, Kumar C, Chance B: Experimental study of migration depth for the photons measured at sample surface. Proc SPIE 1991; 1431:180–91
16.den Uil CA, Klijn E, Lagrand WK, Brugts JJ, Ince C, Spronk PE, Simoons ML: The microcirculation in health and critical disease. Prog Cardiovasc Dis 2008; 51:161–70
17.Cohn SM, Nathens AB, Moore FA, Rhee P, Puyana JC, Moore EE, Beilman GJ: StO2 in Trauma Patients Trial Investigators: Tissue oxygen saturation predicts the development of organ dysfunction during traumatic shock resuscitation. J Trauma 2007; 62:44–54
18.Ikossi DG, Knudson MM, Morabito DJ, Cohen MJ, Wan JJ, Khaw L, Stewart CJ, Hemphill C, Manley GT: Continuous muscle tissue oxygenation in critically injured patients: A prospective observational study. J Trauma 2006; 61:780–8
19.Peltonen JE, Kowalchuk JM, Paterson DH, DeLorey DS, duManoir GR, Petrella RJ, Shoemaker JK: Cerebral and muscle tissue oxygenation in acute hypoxic ventilatory response test. Respir Physiol Neurobiol 2007; 155: 71–81
20.Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368–77
21.Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki LM, Pettilä V: Hemodynamic variables related to outcome in septic shock. Intensive Care Med 2005; 31:1066–71
22.Podbregar M, Mozina H: Skeletal muscle oxygen saturation does not estimate mixed venous oxygen saturation in patients with severe left heart failure and additional severe sepsis or septic shock. Crit Care 2007; 11:R6
23.Mulier KE, Skarda DE, Taylor JH, Myers DE, McGraw MK, Gallea BL, Beilman GJ: Near-infrared spectroscopy in patients with severe sepsis: Correlation with invasive hemodynamic measurements. Surg Infect (Larchmt) 2008; 5:1–5
24.Soller BR, Ryan KL, Rickards CA, Cooke WH, Yan Y, Soyemi OO, Crookes BA, Heard SO, Convertino VA: Oxygen saturation determined from deep muscle, not thenar tissue, is an indicator of central hypovolemia in humans. Crit Care Med 2008; 36:176–82
This article has been cited 8 time(s).
Biomed Research InternationalSkeletal Muscle Oxygen Saturation (StO(2)) Measured by Near-Infrared Spectroscopy in the Critically Ill PatientsBiomed Research International
Journal of Clinical Monitoring and ComputingTissue oxygen saturation as a goal, but when and where should we measure it?Journal of Clinical Monitoring and Computing
Journal of Clinical Monitoring and ComputingStO(2) guided early resuscitation in subjects with severe sepsis or septic shock: a pilot randomised trialJournal of Clinical Monitoring and Computing
Photons Plus Ultrasound: Imaging and Sensing 2013Noninvasive optoacoustic system for rapid diagnosis and management of circulatory shockPhotons Plus Ultrasound: Imaging and Sensing 2013
Journal of Clinical Monitoring and ComputingAssociation of intraoperative tissue oxygenation with suspected risk factors for tissue hypoxiaJournal of Clinical Monitoring and Computing
Critical CareHypoxia-inducible factor (HIF1 alpha) gene expression in human shock statesCritical Care
Critical Care ClinicsThe Optimal HematocritCritical Care Clinics
Critical Care ClinicsOptimizing Hemodynamic Support in Septic Shock Using Central and Mixed Venous Oxygen SaturationCritical Care Clinics
© 2009 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.